Novozymes A/S’ B shares are listed on the OMX Nordic Exchange Copenhagen and are traded under ticker code NZYM B and ISIN DK0010272129 with a nominal value of DKK 10.
Share capital and voting rights
| Share capital (DKK) | Votes | Votes (%) | |
| A shares | 107,487,200 | 1,074,872,000 | 66.5 |
| B shares | 542,512,800 | 542,512,800 | 33.5 |
| Total | 650,000,000 | 1,617,384,800 | 100.0 |
The A share capital is held by Novo A/S, which is wholly owned by the Novo Nordisk Foundation. In addition, Novo A/S holds 5,826,280 B shares, which overall gives Novo A/S 25.5% of the total share capital and 66.8% of the votes. This is why Novozymes is included in the consolidated statements of the Novo Nordisk Foundation. Novo A/S is domiciled in Gladsaxe, Denmark.
Novozymes’ holding of treasury shares has been included when calculating the numbers and percentages of votes held.
Main shareholders
| Name | % of | % of |
| B share | Total share | |
| capital | capital | |
| Novo A/S, Gladsaxe | 10.7% | 25.5% |
| Novozymes A/S, Gladsaxe, Denmark | 5.9% | 4.9% |
| Danish ATP, Hillerød, Denmark | 6.3% | 5.3% |
| Institutional Investors, etc. | 60.3% | 50.3% |
| Private Investors | 16.8% | 14% |
| Total | 100% | 100% |
It is estimated that the number of private shareholders is about 50,000 to 60,000.
Geographical distribution of shareholders
| Country/region | % of | % of |
| B share | Total share | |
| capital | capital | |
| Denmark | 56% | 63% |
| Rest of Europe | 22% | 18% |
| North America | 22% | 19% |
| Rest of the world | 0% | 0% |
| Total | 100 | 100 |